Cell Therapeutics Inc (NASDAQ:CTIC) Long Term Investor Investigation over Potential Wrongdoing
An investigation on behalf of current long-term stockholders of shares of Cell Therapeutics Inc (NASDAQ:CTIC) was announced concerning whether certain Cell Therapeutics officers and directors possibly breached their fiduciary duties in connection with certain statements.
View full press release